GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Argos Therapeutics Inc (FRA:77AA) » Definitions » Shares Buyback Ratio %

Argos Therapeutics (FRA:77AA) Shares Buyback Ratio % : -159.45 (As of Jun. 13, 2024)


View and export this data going back to 2014. Start your Free Trial

What is Argos Therapeutics Shares Buyback Ratio %?

Shares Outstanding (EOP) are shares that have been authorized, issued, and purchased by investors and are held by them.

GuruFocus calculates shares buyback ratio using previous shares outstanding minus the current shares outstanding, and then divides by previous shares outstanding. Argos Therapeutics's current shares buyback ratio was -159.45%.


Argos Therapeutics Shares Buyback Ratio % Historical Data

The historical data trend for Argos Therapeutics's Shares Buyback Ratio % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Argos Therapeutics Shares Buyback Ratio % Chart

Argos Therapeutics Annual Data
Trend Dec09 Dec10 Dec11 Dec12 Dec13 Dec14 Dec15 Dec16 Dec17
Shares Buyback Ratio %
Get a 7-Day Free Trial Premium Member Only -707.16 -3.19 -10.09 -90.67 -186.29

Argos Therapeutics Quarterly Data
Dec13 Mar14 Jun14 Sep14 Dec14 Mar15 Jun15 Sep15 Dec15 Mar16 Jun16 Sep16 Dec16 Mar17 Jun17 Sep17 Dec17 Mar18 Jun18 Sep18
Shares Buyback Ratio % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -86.65 -49.88 -73.11 - -

Argos Therapeutics Shares Buyback Ratio % Calculation

Argos Therapeutics's Shares Buyback Ratio for the fiscal year that ended in Dec. 2017 is calculated as

Shares Buyback Ratio=(Shares Outstanding (EOP) (A: Dec. 2016 ) - Shares Outstanding (EOP) (A: Dec. 2017 )) / Shares Outstanding (EOP) (A: Dec. 2016 )
=(2.06316 - 5.90662) / 2.06316
=-186.29%

Argos Therapeutics's Shares Buyback Ratio for the quarter that ended in Sep. 2018 is calculated as

Shares Buyback Ratio=(Shares Outstanding (EOP) (A: Jun. 2018 ) - Shares Outstanding (EOP) (A: Sep. 2018 )) / Shares Outstanding (EOP) (A: Jun. 2018 )
=(10.2248 - 10.2248) / 10.2248
=0.00%

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Argos Therapeutics Shares Buyback Ratio % Related Terms

Thank you for viewing the detailed overview of Argos Therapeutics's Shares Buyback Ratio % provided by GuruFocus.com. Please click on the following links to see related term pages.


Argos Therapeutics (FRA:77AA) Business Description

Traded in Other Exchanges
N/A
Address
4233 Technology Drive, Durham, NC, USA, 27704
Argos Therapeutics Inc is a biopharmaceutical company. It is engaged in the development and commercialization of immunotherapies for the treatment of cancer and infectious diseases based on its proprietary technology platform called Arcelis.

Argos Therapeutics (FRA:77AA) Headlines

No Headlines